Angiotensin II in the elderly: Impact of angiotensin II type 1 receptor sensitivity on peripheral hemodynamics

Hypertension

Volumn 51, Issue 6, 2008, Pages 1611-1616

  Wray, D Walter ^a,b   Nishiyama, Steven K ^a   Harris, Ryan A ^a   Richardson, Russell S ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin receptors; Basic science; Blood flow regulation; Elderly; Exercise

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; VASOCONSTRICTOR AGENT;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTERIAL PRESSURE; ARTERY DIAMETER; ARTICLE; BLOOD FLOW VELOCITY; CONTINUOUS INFUSION; DOPPLER FLOWMETER; EXERCISE; FEMALE; FEMORAL ARTERY; HEART RATE; HEMODYNAMICS; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LEG BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; REST; SKELETAL MUSCLE; BLOOD; BLOOD FLOW; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; HYPEREMIA; LEG; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION; VASOCONSTRICTION;

ADULT; AGED; AGING; ANGIOTENSIN II; BLOOD FLOW VELOCITY; EXERCISE; HUMANS; HYPEREMIA; LEG; RECEPTOR, ANGIOTENSIN, TYPE 1; REGIONAL BLOOD FLOW; REST; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 45849152058     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.111294     Document Type: Article

References (47)

1. Tsunoda K, Abe K, Goto T, Yasujima M, Sato M, Omata K, Seino M, Yoshinaga K. Effect of age on the renin-angiotensin-aldosterone system in normal subjects: simultaneous measurement of active and inactive renin, renin substrate, and aldosterone in plasma. J Clin Endocrinol Metab. 1986;62:384-389.
2. Duggan J, Nussberger J, Kilfeather S, O'Malley K. Aging and human hormonal and pressor responsiveness to angiotensin II infusion with simultaneous measurement of exogenous and endogenous angiotensin II. Am J Hypertens. 1993;6:641-647.
3. Duggan J, Kilfeather S, O'Brien E, O'Malley K, Nussberger J. Effects of aging and hypertension on plasma angiotensin II and platelet angiotensin II receptor density. Am J Hypertens. 1992;5:687-693.
4. Siebers MJ, Goodfriend TL, Ball D, Elliott ME. Analysis of angiotensin II binding to human platelets: differences in young and old subjects. J Gerontol. 1990;45:B42-B47.
5. Takeda R, Morimoto S, Uchida K, Miyamori I, Hashiba T. Effect of age on plasma aldosterone response to exogenous angiotensin II in normo- tensive subjects. Acta Endocrinol (Copenh). 1980;94:552-558.
6. Hogikyan RV, Supiano MA. Arterial alpha-adrenergic responsiveness is decreased and SNS activity is increased in older humans. Am J Physiol. 1994;266:E717-E724.
7. Dinenno FA, Jones PP, Seals DR, Tanaka H. Limb blood flow and vascular conductance are reduced with age in healthy humans: relation to elevations in sympathetic nerve activity and declines in oxygen demand. Circulation. 1999;100:164-170.
8. Sundlof G, Wallin BG. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol. 1978;274:621-637.
9. Seals DR, Dinenno FA. Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging. Am J Physiol Heart Circ Physiol. 2004;287:H1895-H1905.
10. Dinenno FA, Dietz NM, Joyner MJ. Aging and forearm postjunctional alpha-adrenergic vasoconstriction in healthy men. Circulation. 2002;106: 1349 -1354.
11. Brewster UC, Setaro JF, Perazella MA. The renin-angiotensin-aldoste- rone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci. 2003;326:15-24.
12. Lawrenson L, Poole JG, Kim J, Brown C, Patel P, Richardson RS. Vascular and metabolic response to isolated small muscle mass exercise: effect of age. Am J Physiol Heart Circ Physiol. 2003;285:H1023-H1031.
13. Poole JG, Lawrenson L, Kim J, Brown C, Richardson RS. Vascular and metabolic response to cycle exercise in sedentary humans: effect of age. Am J Physiol Heart Circ Physiol. 2003;284:H1251-H1259.
14. Beere PA, Russell SD, Morey MC, Kitzman DW, Higginbotham MB. Aerobic exercise training can reverse age-related peripheral circulatory changes in healthy older men. Circulation. 1999;100:1085-1094.
15. Proctor DN, Shen PH, Dietz NM, Eickhoff TJ, Lawler LA, Ebersold EJ, Loeffler DL, Joyner MJ. Reduced leg blood flow during dynamic exercise in older endurance-trained men. J Appl Physiol. 1998;85:68-75.
16. Dinenno FA, Masuki S, Joyner MJ. Impaired modulation of sympathetic alpha-adrenergic vasoconstriction in contracting forearm muscle of ageing men. J Physiol. 2005;567:311-321.
17. Fadel PJ, Wang Z, Watanabe H, Arbique D, Vongpatanasin W, Thomas GD. Augmented sympathetic vasoconstriction in exercising forearms of postmenopausal women is reversed by oestrogen therapy. J Physiol. 2004;561:893-901.
18. Brothers RM, Haslund ML, Wray DW, Raven PB, Sander M. Exercise- induced inhibition of angiotensin II vasoconstriction in human thigh muscle. J Physiol. 2006;577:727-737.
19. Andersen P, Adams RP, Sjogaard G, Thorboe A, Saltin B. Dynamic knee extension as model for study of isolated exercising muscle in humans. J Appl Physiol. 1985;59:1647-1653.
20. Wray DW, Uberoi A, Lawrenson L, Richardson RS. Heterogeneous limb vascular responsiveness to shear stimuli during dynamic exercise in humans. J Appl Physiol. 2005;99:81-86.
21. Donato AJ, Uberoi A, Wray DW, Nishiyama S, Lawrenson L, Richardson RS. Differential effects of aging on limb blood flow in humans. Am J Physiol Heart Circ Physiol. 2006;290:H272-H278.
22. Wray DW, Richardson RS. Aging, exercise, and limb vascular heterogeneity in humans. Med Sci Sports Exerc. 2006;38:1804-1810.
23. Dinenno FA, Joyner MJ. Alpha-adrenergic control of skeletal muscle circulation at rest and during exercise in aging humans. Microcirculation. 2006;13:329-341.
24. Belmin J, Levy BI, Michel JB. Changes in the renin-angiotensin-aldoste- rone axis in later life. Drugs Aging. 1994;5:391-400.
25. Dinenno FA, Eisenach JH, Dietz NM, Joyner MJ. Post-junctional alpha- adrenoceptors and basal limb vascular tone in healthy men. J Physiol. 2002;540:1103-1110.
26. Smith EG, Voyles WF, Kirby BS, Markwald RR, Dinenno FA. Ageing
27. and leg postjunctional alpha-adrenergic vasoconstrictor responsiveness in healthy men. J Physiol. 2007;582:63-71.
28. Dinenno FA, Tanaka H, Stauffer BL, Seals DR. Reductions in basal limb blood flow and vascular conductance with human ageing: role for augmented alpha-adrenergic vasoconstriction. J Physiol. 2001;536:977-983.
29. Starke K. Action of angiotensin on uptake, release and metabolism of 14C- noradrenaline by isolated rabbit hearts. Eur J Pharmacol. 1971;14:112-123.
30. Gilles R, Vingerhoedt N, Howes J, Griffin M, Howes LG. Increase in systemic blood pressure during intra-arterial PD123319 infusion: evidence for functional expression of angiotensin type 2 receptors in normal volunteers. Blood Press. 2004;13:110-114.
31. Singh N, Prasad S, Singer DR, MacAllister RJ. Ageing is associated with impairment of nitric oxide and prostanoid dilator pathways in the human forearm. Clin Sci (Lond). 2002;102:595-600.
32. Dinenno FA, Joyner MJ. Blunted sympathetic vasoconstriction in contracting skeletal muscle of healthy humans: is nitric oxide obligatory? J Physiol. 2003;553:281-292.
33. Wray DW, Fadel PJ, Smith ML, Raven P, Sander M. Inhibition of alpha-adrenergic vasoconstriction in exercising human thigh muscles. J Physiol. 2004;555:545-563.
34. Rosenmeier JB, Dinenno FA, Fritzlar SJ, Joyner MJ. alpha1- and alpha2- adrenergic vasoconstriction is blunted in contracting human muscle. J Physiol. 2003;547:971-976.
35. Wray DW, Nishiyama SK, Donato AJ, Sander M, Wagner PD, Richardson RS. Endothelin-1-mediated vasoconstriction at rest and during dynamic exercise in healthy humans. Amer J Physiol Heart Circ Physiol. 2007; 293:H2550-H2556.
36. Tidgren B, Hjemdahl P, Theodorsson E, Nussberger J. Renal neuro- hormonal and vascular responses to dynamic exercise in humans. J Appl Physiol. 1991;70:2279 -2286.
37. Stebbins CL, Symons JD. Role of angiotensin II in hemodynamic responses to dynamic exercise in miniswine. J Appl Physiol. 1995;78:185-190.
38. Symons JD, Stebbins CL. Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin. J Cardiovasc Pharmacol. 1996;28:223-231.
39. Appel GB, Appel AS. Angiotensin II receptor antagonists: role in hypertension, cardiovascular disease, and renoprotection. Prog Cardiovasc Dis. 2004;47:105-115.
40. Ferrario CM. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst. 2006;7:3-14.
41. Burnier M. Angiotensin II type 1 receptor blockers. Circulation. 2001; 103:904-912.
42. Rosendorff C. Vascular hypertrophy in hypertension: role of the renin-angiotensin system. Mt Sinai J Med. 1998;65:108-117.
43. Newby DE, Goodfield NE, Flapan AD, Boon NA, Fox KA, Webb DJ. Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II. Heart. 1998;80:134-140.
44. Warner JG Jr, Metzger DC, Kitzman DW, Wesley DJ, Little WC. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol. 1999;33:1567-1572.
45. Simpson KL, McClellan KJ. Losartan: a review of its use, with special focus on elderly patients. Drugs Aging. 2000;16:227-250.
46. Zucker IH, Wang W, Brandle M, Schultz HD, Patel KP. Neural regulation of sympathetic nerve activity in heart failure. Prog Cardiovasc Dis. 1995;37:397- 414.
47. Rheaume C, Waib PH, Lacourciere Y, Cleroux J. Effects of angiotensin antagonism with tasosartan on regional and systemic haemodynamics in hypertensive patients. J Hyper. 1998;16:2085-2089.